Bladder leiomyoma and the utility of 18F-Fluorodeoxyglucose-Positron Emission Tomography – a Case Report

© 2023 by the author. Licensee POL Scientific, USA. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )

Download PDF

Cite

XML

Abstract

Bladder leiomyomas are rare neoplasms and various diagnostic methods are available to assist in confirming diagnosis preoperatively. Presented here is a case of bladder leiomyoma in a 41-year-old female who presented with urinary symptoms and right thigh pain. Imaging revealed a soft tissue density mass in the bladder wall. However concerns of a leiomyosarcoma remained. An ¹⁸F-fluorodeoxyglucose (FDG) positron emission tomography/computerized tomography (PET/CT) demonstrated low FDG uptake and absence of metastatic lesions. In combination with operative findings, the tumor allowed for localized resection instead of more invasive partial cystectomy. Therefore, FDG-PET might be used to support the diagnosis of leiomyoma and potentially facilitate a less aggressive surgical management.

Keywords

Benign bladder tumor;

Bladder leiomyoma

FDG-PET

Radiology

References

1. Khater N, Sakr G. Bladder leiomyoma: Presentation, evaluation and treatment. Arab J Urol. 2013 Mar;11(1):54–61. https://doi.org/10.1016/j.aju.2012.11.007 PMID:26579246
2. DeMulder D, Ascher SM. Uterine leiomyosarcoma: can MRI differentiate leiomyosarcoma from benign leiomyoma before treatment? AJR Am J Roentgenol. 2018 Dec;211(6):1405–15. https://doi.org/10.2214/AJR.17.19234 PMID:30354268
3. Park JY, Lee JW, Lee HJ, Lee JJ, Moon SH, Kang SY, et al. Prognostic significance of preoperative ¹⁸F-FDG PET/CT in uterine leiomyosarcoma. J Gynecol Oncol. 2017 May;28(3):e28. https://doi.org/10.3802/jgo.2017.28.e28 PMID:28382795
4. Kitajima K, Murakami K, Yamasaki E, Kaji Y, Sugimura K. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI. Ann Nucl Med. 2008 Jul;22(6):505–12. https://doi.org/10.1007/s12149-008-0135-2 PMID:18670857
5. Kitajima K, Murakami K, Kaji Y, Sugimura K. Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol. 2010 Sep;195(3):737–43. https://doi.org/10.2214/AJR.09.4074 PMID:20729454
6. Makis W, Rakheja R, Nahal A, Hickeson M, Lisbona R. Urinary Bladder Leiomyosarcoma: Staging With: 18: F-FDG PET/CT. Clinical Nuclear Medicine. 2013 May 1;38(5):e218-22. https://doi.org/10.1097/RLU.0b013e3182523e33 PMID: 23377410
7. Sharma A, Vadi SK, Sood A, Kumar S, Mete UK, Parkhi M, Mittal BR. Bladder leiomyoma: A rare differential and a potential pitfall in the evaluation for a bladder mass in 18F-Fluorodeoxyglucose-positron emission tomography/computed tomography. Indian J Nucl Med. 2018 Jul;33(3):264. https://doi.org/10.4103/ijnm.IJNM_40_18 PMID:29962734

Previous article in this issue

Next article in this issue

Bladder, Electronic ISSN: 2327-2120 Print ISSN: TBA, Published by POL Scientific

Publisher's Core Philosophy

We are committed to support the scientific community by publishing impactful research and enhancing communication among scientists. At POL Scientific, we are continuously looking for ways to accelerate scientific progress and to strive for transparency and open communication, making knowledge freely accessible without barrier.

171 Skyview St. San Francisco, CA 94131 U.S.A.

info@polscientific.com